2024-09-10 - Analysis Report
## Pfizer (PFE) Stock Analysis

**1. Performance Overview**

Pfizer (PFE) is a pharmaceutical company developing and manufacturing medicines and vaccines. Its stock has underperformed the S&P 500 (VOO) significantly, with a cumulative return of -27.44% compared to VOO's 81.34%. The gap between the two is -108.78%, placing it in the bottom 7.37% of historical performance.

**2. Recent Price Trends**

PFE's closing price is currently at $28.56, slightly below its 5-day moving average of $28.55. It is also below its 20-day ($28.71) and 60-day ($28.81) moving averages, suggesting a potential downtrend. 

**3. Technical Indicators**

* **RSI:** 55.04, indicating a neutral market sentiment.
* **PPO:** -0.11, suggesting a potential downtrend as it is negative.
* **Delta_Previous_Relative_Divergence:** -2.5, pointing to a recent short-term decline in price.
* **Expected Return:** 0.0%, indicating a potential for zero returns in the next 5 years. 

**4. Recent Earnings and Outlook**

Pfizer's recent earnings have shown mixed results:

| Date       | EPS | Expected EPS |
|------------|-----|---------------|
| 2024-07-30 | 0.6 | 0.458        |
| 2024-05-01 | 0.82 | 0.516        |
| 2024-01-30 | 0.1 | -0.19        |
| 2023-10-31 | -0.17| -0.32        |
| 2023-08-01 | 0.67 | 0.56        |

The most recent earnings (2024-07-30) beat expectations, but the overall trend suggests a volatile performance.

**5. Overall Analysis**

PFE has significantly underperformed the market, with a substantial gap in returns compared to VOO. Recent price action shows a potential downtrend, confirmed by negative PPO and declining relative divergence. While the most recent earnings beat expectations, the overall trend suggests mixed results. 

**6. Conclusion**

Based on the analysis, PFE currently faces several challenges, including underperformance relative to the market, a potentially downtrending price, and mixed earnings performance. Investors should carefully consider these factors and monitor future developments before making any investment decisions.  
